Efficacy and Adverse Reaction of Tislelizumab Combined with Chemotherapy on Urothelial Carcinoma

Efficacy and Adverse Reaction of Tislelizumab Combined with Chemotherapy on Urothelial Carcinoma

Objective To evaluate the efficacy and safety of tislelizumab combined with chemotherapy in the treatment of urothelial carcinoma in the real word. Methods We enrolled 32 patients with urothelial carcinoma who were treated with tislelizumab and chemotherapy (gemcitabine/cisplatin or paclitaxel). The...

Full description

Bibliographic Details
Main Authors: WEI Zongjie, KUANG Youlin, CHEN Yong, WANG Lu, CHEN Xiao, GOU Xin
Format: Article
Language:zho
Published: Magazine House of Cancer Research on Prevention and Treatment 2022-07-01
Series:Zhongliu Fangzhi Yanjiu
Subjects:
tislelizumab
chemotherapy
urothelial cancer
efficacy
adverse reaction
Online Access:http://www.zlfzyj.com/EN/10.3971/j.issn.1000-8578.2022.21.1340

Internet

http://www.zlfzyj.com/EN/10.3971/j.issn.1000-8578.2022.21.1340

Similar Items